Adderall Prescription Supply Duration
Federal law permits 90-day prescriptions for Schedule II controlled substances like Adderall, but practical barriers—including insurance restrictions, clinical monitoring requirements, and diversion risk—typically limit prescriptions to 30-day supplies. 1
Federal Regulations vs. Clinical Practice
Federal DEA regulations do not prohibit 90-day prescriptions for Schedule II stimulants, but state laws vary and should be verified in your jurisdiction. 1
Insurance companies routinely restrict Schedule II medications to 30-day supplies regardless of what the prescription specifies, often requiring prior authorization for any extended supply. 1
Clinical guidelines from the American Academy of Child and Adolescent Psychiatry recommend monthly follow-up appointments until symptoms stabilize on a consistent dose, which naturally aligns with 30-day prescription intervals during titration. 1
Why 30-Day Supplies Are Standard Practice
Diversion risk is a major concern, particularly in adolescents and adults, as Schedule II stimulants have high abuse potential and may be shared, sold, or used for non-medical purposes. 1
Monthly monitoring is essential during maintenance treatment to systematically assess blood pressure, pulse, weight, sleep quality, appetite changes, and signs of medication misuse. 1
Dose adjustments are common, and monthly prescriptions allow for ongoing clinical assessment and optimization without wasting medication if changes are needed. 1
Special Populations Requiring Shorter Intervals
Patients with comorbid substance use disorders should receive even shorter prescription intervals—potentially weekly supplies—with close monitoring for signs of misuse. 1
New patients or those with unstable symptoms require more frequent clinical contact, making monthly prescriptions appropriate for ongoing assessment and safety monitoring. 1
Practical Approach
Start with 30-day supplies as the default for all patients on Adderall, given insurance limitations and clinical monitoring needs. 1
Consider 90-day supplies only for highly stable patients with documented adherence, no diversion risk, and insurance approval—but expect this to be the exception rather than the rule. 1
Verify your state's specific regulations, as some states impose additional restrictions beyond federal DEA requirements on Schedule II prescribing. 1